 David Mirsky
Concepts (417)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 46 | 2025 | 3637 | 3.290 |
Why?
| | Hydrocephalus | 6 | 2023 | 108 | 2.220 |
Why?
| | Prenatal Diagnosis | 7 | 2022 | 188 | 1.900 |
Why?
| | Stroke | 14 | 2022 | 1136 | 1.510 |
Why?
| | Craniocerebral Trauma | 6 | 2025 | 170 | 1.470 |
Why?
| | Neuroimaging | 10 | 2024 | 263 | 1.360 |
Why?
| | Brain | 15 | 2022 | 2792 | 1.350 |
Why?
| | Child Abuse | 7 | 2025 | 542 | 1.290 |
Why?
| | Cerebrospinal Fluid Shunts | 2 | 2020 | 29 | 1.170 |
Why?
| | Brain Neoplasms | 9 | 2025 | 1267 | 1.110 |
Why?
| | Tomography, X-Ray Computed | 13 | 2024 | 2698 | 1.040 |
Why?
| | Central Nervous System Neoplasms | 3 | 2025 | 165 | 1.010 |
Why?
| | Child | 57 | 2025 | 21921 | 0.990 |
Why?
| | Neural Tube Defects | 2 | 2018 | 61 | 0.970 |
Why?
| | Craniopharyngioma | 5 | 2025 | 73 | 0.900 |
Why?
| | Fetus | 6 | 2022 | 799 | 0.890 |
Why?
| | Turbinates | 1 | 2024 | 14 | 0.890 |
Why?
| | Retrospective Studies | 37 | 2025 | 15909 | 0.850 |
Why?
| | Nervous System Malformations | 2 | 2023 | 43 | 0.850 |
Why?
| | Head and Neck Neoplasms | 3 | 2022 | 549 | 0.840 |
Why?
| | Placenta Accreta | 1 | 2024 | 29 | 0.830 |
Why?
| | Megalencephaly | 1 | 2022 | 20 | 0.760 |
Why?
| | Circle of Willis | 1 | 2022 | 7 | 0.750 |
Why?
| | Epidermal Cyst | 1 | 2022 | 13 | 0.740 |
Why?
| | Dermoid Cyst | 1 | 2022 | 14 | 0.740 |
Why?
| | Infant | 24 | 2025 | 9574 | 0.730 |
Why?
| | Child, Preschool | 32 | 2025 | 11158 | 0.720 |
Why?
| | Contrast Media | 4 | 2022 | 463 | 0.720 |
Why?
| | Humans | 107 | 2025 | 138651 | 0.720 |
Why?
| | Pituitary Neoplasms | 4 | 2025 | 192 | 0.690 |
Why?
| | Nasal Obstruction | 1 | 2021 | 27 | 0.680 |
Why?
| | Neck | 4 | 2022 | 104 | 0.670 |
Why?
| | Infant, Newborn, Diseases | 2 | 2019 | 113 | 0.660 |
Why?
| | Central Nervous System Infections | 2 | 2018 | 35 | 0.660 |
Why?
| | Ependymoma | 1 | 2022 | 163 | 0.660 |
Why?
| | Gadolinium DTPA | 2 | 2019 | 69 | 0.650 |
Why?
| | Intracranial Hemorrhages | 2 | 2019 | 89 | 0.640 |
Why?
| | Temporal Lobe | 1 | 2019 | 102 | 0.600 |
Why?
| | Cavernous Sinus Thrombosis | 2 | 2015 | 8 | 0.590 |
Why?
| | Anatomic Landmarks | 1 | 2018 | 30 | 0.590 |
Why?
| | Thrombosis | 1 | 2022 | 374 | 0.580 |
Why?
| | Occipital Lobe | 1 | 2017 | 23 | 0.540 |
Why?
| | Female | 56 | 2025 | 73763 | 0.540 |
Why?
| | Spinal Cord | 2 | 2021 | 373 | 0.520 |
Why?
| | Cerebral Hemorrhage | 1 | 2017 | 114 | 0.510 |
Why?
| | Facial Injuries | 1 | 2016 | 23 | 0.510 |
Why?
| | Pediatrics | 4 | 2019 | 1078 | 0.500 |
Why?
| | Frontal Lobe | 1 | 2017 | 160 | 0.490 |
Why?
| | Brain Diseases | 2 | 2020 | 148 | 0.490 |
Why?
| | Pregnancy | 14 | 2025 | 6829 | 0.480 |
Why?
| | Carotid Stenosis | 2 | 2015 | 96 | 0.480 |
Why?
| | Head | 2 | 2019 | 115 | 0.480 |
Why?
| | Spinal Injuries | 3 | 2022 | 56 | 0.480 |
Why?
| | Tissue Adhesions | 1 | 2015 | 32 | 0.480 |
Why?
| | Societies, Medical | 6 | 2022 | 839 | 0.470 |
Why?
| | Lymphatic Abnormalities | 2 | 2012 | 20 | 0.470 |
Why?
| | Cerebral Infarction | 1 | 2015 | 49 | 0.470 |
Why?
| | Craniofacial Abnormalities | 2 | 2012 | 74 | 0.450 |
Why?
| | Ultrasonography, Prenatal | 3 | 2022 | 287 | 0.450 |
Why?
| | Hypothalamus | 1 | 2015 | 153 | 0.450 |
Why?
| | Central Nervous System Diseases | 1 | 2015 | 72 | 0.450 |
Why?
| | Prevalence | 5 | 2024 | 2727 | 0.420 |
Why?
| | Infant, Newborn | 14 | 2022 | 6144 | 0.410 |
Why?
| | Male | 41 | 2025 | 68260 | 0.400 |
Why?
| | Dandy-Walker Syndrome | 2 | 2023 | 7 | 0.400 |
Why?
| | Proto-Oncogene Proteins B-raf | 4 | 2023 | 222 | 0.390 |
Why?
| | Stomatognathic Diseases | 1 | 2012 | 4 | 0.390 |
Why?
| | Goiter | 1 | 2012 | 5 | 0.380 |
Why?
| | Adolescent | 22 | 2025 | 21564 | 0.370 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 2 | 2025 | 116 | 0.360 |
Why?
| | Meningomyelocele | 2 | 2022 | 59 | 0.350 |
Why?
| | Magnetic Resonance Angiography | 3 | 2019 | 243 | 0.350 |
Why?
| | Brain Ischemia | 3 | 2022 | 343 | 0.340 |
Why?
| | Fetal Diseases | 1 | 2012 | 177 | 0.340 |
Why?
| | Sinusitis | 3 | 2018 | 237 | 0.330 |
Why?
| | Sacrum | 3 | 2018 | 71 | 0.320 |
Why?
| | Diagnosis, Differential | 7 | 2019 | 1482 | 0.320 |
Why?
| | Infarction, Middle Cerebral Artery | 3 | 2022 | 43 | 0.310 |
Why?
| | Hypothalamic Diseases | 2 | 2022 | 18 | 0.310 |
Why?
| | Emergency Medical Services | 1 | 2015 | 634 | 0.290 |
Why?
| | Postoperative Complications | 2 | 2018 | 2722 | 0.290 |
Why?
| | Anorectal Malformations | 2 | 2021 | 112 | 0.280 |
Why?
| | Neurodevelopmental Disorders | 2 | 2025 | 184 | 0.280 |
Why?
| | Mitochondrial Diseases | 2 | 2020 | 91 | 0.280 |
Why?
| | Evidence-Based Medicine | 6 | 2022 | 745 | 0.280 |
Why?
| | Prenatal Care | 4 | 2022 | 295 | 0.280 |
Why?
| | Placenta | 2 | 2025 | 753 | 0.280 |
Why?
| | Gestational Age | 4 | 2025 | 916 | 0.260 |
Why?
| | Brain Injuries, Traumatic | 2 | 2025 | 381 | 0.260 |
Why?
| | Teratoma | 2 | 2019 | 118 | 0.260 |
Why?
| | Cerebrovascular Disorders | 2 | 2020 | 96 | 0.250 |
Why?
| | Muscular Diseases | 2 | 2020 | 112 | 0.250 |
Why?
| | Brain Injuries | 2 | 2025 | 501 | 0.240 |
Why?
| | Priapism | 1 | 2005 | 11 | 0.240 |
Why?
| | Penis | 1 | 2005 | 34 | 0.240 |
Why?
| | Chloroquine | 2 | 2017 | 52 | 0.240 |
Why?
| | Hematoma, Subdural | 2 | 2022 | 20 | 0.230 |
Why?
| | Vertebral Artery Dissection | 2 | 2022 | 25 | 0.230 |
Why?
| | Sotos Syndrome | 1 | 2024 | 2 | 0.230 |
Why?
| | Malformations of Cortical Development | 1 | 2024 | 13 | 0.220 |
Why?
| | Brain Edema | 1 | 2025 | 64 | 0.220 |
Why?
| | Glycosylphosphatidylinositols | 1 | 2024 | 12 | 0.220 |
Why?
| | Nasal Septum | 1 | 2024 | 25 | 0.220 |
Why?
| | Placental Circulation | 1 | 2025 | 71 | 0.220 |
Why?
| | Mastectomy, Segmental | 2 | 2001 | 97 | 0.210 |
Why?
| | Microvessels | 1 | 2025 | 86 | 0.210 |
Why?
| | Antineoplastic Agents | 3 | 2025 | 2152 | 0.210 |
Why?
| | Disease Progression | 2 | 2024 | 2749 | 0.210 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2025 | 154 | 0.200 |
Why?
| | Tumor Burden | 1 | 2024 | 309 | 0.200 |
Why?
| | Ventriculoperitoneal Shunt | 2 | 2020 | 37 | 0.200 |
Why?
| | Phenotype | 4 | 2024 | 3139 | 0.200 |
Why?
| | Embolization, Therapeutic | 1 | 2005 | 234 | 0.200 |
Why?
| | Autophagy | 2 | 2017 | 285 | 0.200 |
Why?
| | Medical Oncology | 1 | 2025 | 304 | 0.200 |
Why?
| | Physical Abuse | 1 | 2023 | 39 | 0.200 |
Why?
| | Neck Injuries | 1 | 2022 | 20 | 0.190 |
Why?
| | Surface Plasmon Resonance | 1 | 2022 | 88 | 0.190 |
Why?
| | Central Nervous System Vascular Malformations | 1 | 2022 | 25 | 0.190 |
Why?
| | Constriction, Pathologic | 2 | 2021 | 237 | 0.190 |
Why?
| | Indoles | 2 | 2017 | 414 | 0.190 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 9 | 0.190 |
Why?
| | Pyrimidinones | 1 | 2023 | 114 | 0.180 |
Why?
| | Sulfonamides | 2 | 2017 | 505 | 0.180 |
Why?
| | Cysts | 1 | 2022 | 114 | 0.180 |
Why?
| | Migraine Disorders | 1 | 2023 | 105 | 0.180 |
Why?
| | Artificial Intelligence | 1 | 2025 | 295 | 0.180 |
Why?
| | Epilepsy | 2 | 2016 | 335 | 0.180 |
Why?
| | Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 78 | 0.180 |
Why?
| | Neuroblastoma | 1 | 2022 | 159 | 0.170 |
Why?
| | Decision Support Systems, Clinical | 1 | 2025 | 253 | 0.170 |
Why?
| | Pyridones | 1 | 2023 | 170 | 0.170 |
Why?
| | Intracranial Aneurysm | 1 | 2022 | 98 | 0.170 |
Why?
| | White Matter | 1 | 2023 | 144 | 0.170 |
Why?
| | Carcinoma, Ductal, Breast | 1 | 2001 | 81 | 0.170 |
Why?
| | Pituitary Diseases | 1 | 2020 | 20 | 0.170 |
Why?
| | Vitamin B 12 | 1 | 2021 | 125 | 0.170 |
Why?
| | Methionine | 1 | 2021 | 159 | 0.170 |
Why?
| | Breast | 1 | 2001 | 158 | 0.170 |
Why?
| | Seizures | 3 | 2024 | 431 | 0.170 |
Why?
| | Sutures | 1 | 2021 | 60 | 0.170 |
Why?
| | Clinical Trials as Topic | 1 | 2025 | 1034 | 0.170 |
Why?
| | Nasal Cavity | 1 | 2021 | 57 | 0.170 |
Why?
| | Mitochondrial Proton-Translocating ATPases | 1 | 2020 | 19 | 0.170 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2020 | 36 | 0.170 |
Why?
| | Arnold-Chiari Malformation | 1 | 2020 | 27 | 0.170 |
Why?
| | Oxidoreductases Acting on Sulfur Group Donors | 1 | 2020 | 11 | 0.160 |
Why?
| | Mammography | 1 | 2001 | 156 | 0.160 |
Why?
| | Glioma | 1 | 2025 | 407 | 0.160 |
Why?
| | Quinone Reductases | 1 | 2020 | 17 | 0.160 |
Why?
| | Leigh Disease | 1 | 2020 | 22 | 0.160 |
Why?
| | Pituitary Gland | 1 | 2020 | 150 | 0.160 |
Why?
| | Tyrosine | 1 | 2020 | 227 | 0.160 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2020 | 87 | 0.160 |
Why?
| | Spasms, Infantile | 1 | 2021 | 126 | 0.160 |
Why?
| | Sequence Analysis, DNA | 2 | 2020 | 819 | 0.160 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 44 | 0.160 |
Why?
| | RNA, Transfer | 1 | 2020 | 139 | 0.160 |
Why?
| | United States | 11 | 2025 | 14938 | 0.150 |
Why?
| | DNA, Mitochondrial | 1 | 2020 | 208 | 0.150 |
Why?
| | Optic Nerve Neoplasms | 1 | 2019 | 11 | 0.150 |
Why?
| | Optic Chiasm | 1 | 2019 | 18 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2025 | 558 | 0.150 |
Why?
| | Central Nervous System Viral Diseases | 1 | 2020 | 76 | 0.150 |
Why?
| | Taenia solium | 1 | 2018 | 5 | 0.150 |
Why?
| | Neurocysticercosis | 1 | 2018 | 8 | 0.150 |
Why?
| | Ilium | 1 | 2018 | 29 | 0.150 |
Why?
| | Foramen Magnum | 1 | 2018 | 10 | 0.150 |
Why?
| | Occipital Bone | 1 | 2018 | 18 | 0.140 |
Why?
| | Sphenoid Bone | 1 | 2018 | 17 | 0.140 |
Why?
| | Radiology | 1 | 2020 | 164 | 0.140 |
Why?
| | Developmental Disabilities | 2 | 2024 | 268 | 0.140 |
Why?
| | Soft Tissue Neoplasms | 1 | 2019 | 116 | 0.140 |
Why?
| | Skull Base | 1 | 2018 | 51 | 0.140 |
Why?
| | Reference Values | 1 | 2019 | 799 | 0.140 |
Why?
| | Area Under Curve | 1 | 2018 | 319 | 0.140 |
Why?
| | Toxoplasmosis | 1 | 2018 | 40 | 0.140 |
Why?
| | Fecal Incontinence | 1 | 2018 | 89 | 0.140 |
Why?
| | Adenoidectomy | 1 | 2018 | 72 | 0.140 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 8 | 0.140 |
Why?
| | Epilepsies, Partial | 1 | 2018 | 50 | 0.140 |
Why?
| | Central Nervous System | 2 | 2022 | 263 | 0.130 |
Why?
| | Olfaction Disorders | 1 | 2018 | 67 | 0.130 |
Why?
| | Sensitivity and Specificity | 2 | 2020 | 1941 | 0.130 |
Why?
| | Radiation Dosage | 1 | 2019 | 188 | 0.130 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2018 | 144 | 0.130 |
Why?
| | Herpes Simplex | 1 | 2018 | 95 | 0.130 |
Why?
| | Common Data Elements | 1 | 2017 | 14 | 0.130 |
Why?
| | Coccyx | 1 | 2017 | 4 | 0.130 |
Why?
| | Choroid Neoplasms | 1 | 2017 | 8 | 0.130 |
Why?
| | Adult | 11 | 2025 | 38201 | 0.130 |
Why?
| | Fetal Movement | 1 | 2016 | 7 | 0.130 |
Why?
| | Olfactory Bulb | 1 | 2018 | 94 | 0.130 |
Why?
| | Cerebral Arteries | 1 | 2017 | 59 | 0.130 |
Why?
| | Fetal Monitoring | 1 | 2016 | 20 | 0.130 |
Why?
| | Mitochondria | 2 | 2020 | 955 | 0.130 |
Why?
| | ROC Curve | 1 | 2018 | 562 | 0.130 |
Why?
| | Diazepam | 1 | 2016 | 35 | 0.130 |
Why?
| | Tertiary Care Centers | 1 | 2017 | 168 | 0.130 |
Why?
| | Spondylolysis | 1 | 2016 | 7 | 0.130 |
Why?
| | Positron-Emission Tomography | 1 | 2018 | 304 | 0.130 |
Why?
| | Organ Size | 1 | 2017 | 471 | 0.130 |
Why?
| | Anti-Anxiety Agents | 1 | 2016 | 43 | 0.130 |
Why?
| | Drug Resistant Epilepsy | 1 | 2018 | 103 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 564 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2020 | 748 | 0.120 |
Why?
| | Cytomegalovirus Infections | 1 | 2018 | 195 | 0.120 |
Why?
| | Osteomyelitis | 1 | 2018 | 139 | 0.120 |
Why?
| | Balamuthia mandrillaris | 1 | 2015 | 4 | 0.120 |
Why?
| | Amebiasis | 1 | 2015 | 5 | 0.120 |
Why?
| | Genome, Microbial | 1 | 2015 | 7 | 0.120 |
Why?
| | Intracranial Thrombosis | 1 | 2015 | 17 | 0.120 |
Why?
| | Third Ventricle | 1 | 2015 | 16 | 0.120 |
Why?
| | Fracture Fixation | 1 | 2016 | 81 | 0.120 |
Why?
| | Hamartoma | 1 | 2015 | 22 | 0.120 |
Why?
| | Zika Virus Infection | 1 | 2018 | 163 | 0.120 |
Why?
| | Genome, Mitochondrial | 1 | 2015 | 28 | 0.120 |
Why?
| | Headache | 3 | 2023 | 147 | 0.120 |
Why?
| | Infant, Premature, Diseases | 1 | 2017 | 105 | 0.120 |
Why?
| | Endocrine System Diseases | 1 | 2015 | 35 | 0.120 |
Why?
| | Antibiotic Prophylaxis | 1 | 2016 | 121 | 0.120 |
Why?
| | Eye Infections, Fungal | 1 | 2015 | 20 | 0.120 |
Why?
| | Encephalomyelitis, Acute Disseminated | 1 | 2015 | 11 | 0.120 |
Why?
| | Onchocerciasis | 1 | 2015 | 7 | 0.120 |
Why?
| | Orbital Cellulitis | 1 | 2015 | 17 | 0.120 |
Why?
| | Pyridoxine | 1 | 2015 | 36 | 0.110 |
Why?
| | Eye Infections, Bacterial | 1 | 2015 | 39 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 370 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2015 | 41 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 367 | 0.110 |
Why?
| | Spinal Cord Diseases | 1 | 2015 | 43 | 0.110 |
Why?
| | Breast Neoplasms | 3 | 2001 | 2212 | 0.110 |
Why?
| | Software | 1 | 2020 | 668 | 0.110 |
Why?
| | Cohort Studies | 3 | 2024 | 5697 | 0.110 |
Why?
| | Paralysis | 1 | 2015 | 70 | 0.110 |
Why?
| | Emergencies | 1 | 2015 | 178 | 0.110 |
Why?
| | Cranial Nerve Diseases | 1 | 2014 | 42 | 0.110 |
Why?
| | Paraplegia | 1 | 2014 | 61 | 0.110 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2017 | 801 | 0.110 |
Why?
| | Cerebral Arterial Diseases | 1 | 2014 | 49 | 0.110 |
Why?
| | Glasgow Coma Scale | 2 | 2025 | 200 | 0.110 |
Why?
| | Bone Neoplasms | 1 | 2017 | 246 | 0.110 |
Why?
| | Perioperative Care | 1 | 2016 | 213 | 0.110 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 249 | 0.110 |
Why?
| | Nervous System Diseases | 1 | 2017 | 273 | 0.110 |
Why?
| | Encephalitis | 1 | 2015 | 136 | 0.100 |
Why?
| | Fetal Therapies | 1 | 2014 | 45 | 0.100 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1482 | 0.100 |
Why?
| | Arginine | 1 | 2015 | 261 | 0.100 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 64 | 0.100 |
Why?
| | Neuromyelitis Optica | 1 | 2015 | 134 | 0.100 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2015 | 272 | 0.100 |
Why?
| | Enterovirus D, Human | 1 | 2014 | 85 | 0.100 |
Why?
| | Hippocampus | 1 | 2018 | 929 | 0.100 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2020 | 2113 | 0.100 |
Why?
| | Lysine | 1 | 2015 | 290 | 0.100 |
Why?
| | Otitis Media | 1 | 2015 | 167 | 0.100 |
Why?
| | Pharyngeal Diseases | 1 | 2012 | 16 | 0.100 |
Why?
| | Glucocorticoids | 1 | 2016 | 528 | 0.090 |
Why?
| | Logistic Models | 1 | 2017 | 2065 | 0.090 |
Why?
| | Enterovirus Infections | 1 | 2014 | 172 | 0.090 |
Why?
| | Cranial Fossa, Posterior | 2 | 2022 | 18 | 0.090 |
Why?
| | HIV Infections | 2 | 2018 | 2941 | 0.090 |
Why?
| | Amino Acids | 1 | 2015 | 496 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2018 | 3523 | 0.090 |
Why?
| | Incidence | 1 | 2017 | 2747 | 0.080 |
Why?
| | Mutation | 5 | 2021 | 3987 | 0.080 |
Why?
| | Young Adult | 4 | 2024 | 13305 | 0.080 |
Why?
| | Electron Transport Complex IV | 2 | 2020 | 60 | 0.080 |
Why?
| | Herpesvirus 3, Human | 1 | 2014 | 331 | 0.080 |
Why?
| | Herpes Zoster | 1 | 2014 | 314 | 0.080 |
Why?
| | Risk Factors | 5 | 2025 | 10252 | 0.080 |
Why?
| | Cerebellum | 2 | 2022 | 218 | 0.080 |
Why?
| | Physical Examination | 2 | 2023 | 238 | 0.080 |
Why?
| | Anti-Bacterial Agents | 2 | 2016 | 1818 | 0.080 |
Why?
| | Ultrasonography | 2 | 2021 | 745 | 0.080 |
Why?
| | Brain Stem | 2 | 2023 | 96 | 0.080 |
Why?
| | Cervical Vertebrae | 2 | 2022 | 143 | 0.070 |
Why?
| | Prognosis | 3 | 2023 | 3984 | 0.060 |
Why?
| | Cerebrospinal Fluid | 2 | 2018 | 91 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2851 | 0.060 |
Why?
| | Family | 2 | 2021 | 677 | 0.060 |
Why?
| | Recurrence | 2 | 2022 | 1084 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2022 | 5112 | 0.060 |
Why?
| | Age Factors | 2 | 2025 | 3256 | 0.060 |
Why?
| | Spinal Fractures | 1 | 2005 | 74 | 0.060 |
Why?
| | Angiography | 1 | 2005 | 207 | 0.060 |
Why?
| | Drug Synergism | 2 | 2017 | 368 | 0.060 |
Why?
| | Congenital Disorders of Glycosylation | 1 | 2024 | 13 | 0.060 |
Why?
| | Endarterectomy, Carotid | 1 | 2004 | 54 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2025 | 205 | 0.050 |
Why?
| | Europe | 1 | 2025 | 407 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2024 | 215 | 0.050 |
Why?
| | Radiography, Interventional | 1 | 2004 | 119 | 0.050 |
Why?
| | Prospective Studies | 4 | 2021 | 7554 | 0.050 |
Why?
| | Algorithms | 2 | 2022 | 1740 | 0.050 |
Why?
| | Carotid Arteries | 1 | 2004 | 195 | 0.050 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2024 | 134 | 0.050 |
Why?
| | Injury Severity Score | 1 | 2025 | 544 | 0.050 |
Why?
| | Intellectual Disability | 1 | 2024 | 168 | 0.050 |
Why?
| | Cranial Sinuses | 1 | 2022 | 14 | 0.050 |
Why?
| | Ataxia | 1 | 2022 | 70 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 53 | 0.050 |
Why?
| | Siblings | 1 | 2023 | 216 | 0.050 |
Why?
| | Vertebral Artery | 1 | 2022 | 27 | 0.050 |
Why?
| | Wounds, Gunshot | 1 | 2005 | 237 | 0.050 |
Why?
| | 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2021 | 18 | 0.050 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 2021 | 25 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2022 | 199 | 0.040 |
Why?
| | Metabolism, Inborn Errors | 1 | 2021 | 40 | 0.040 |
Why?
| | Time and Motion Studies | 1 | 2001 | 26 | 0.040 |
Why?
| | Biopsy | 2 | 2001 | 1072 | 0.040 |
Why?
| | Retinal Hemorrhage | 1 | 2021 | 22 | 0.040 |
Why?
| | Adrenocorticotropic Hormone | 1 | 2021 | 148 | 0.040 |
Why?
| | Homocysteine | 1 | 2021 | 154 | 0.040 |
Why?
| | Radiography | 1 | 2023 | 841 | 0.040 |
Why?
| | Neuroradiography | 1 | 2020 | 5 | 0.040 |
Why?
| | Radiologists | 1 | 2020 | 49 | 0.040 |
Why?
| | Stents | 1 | 2004 | 526 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2021 | 239 | 0.040 |
Why?
| | Efficiency, Organizational | 1 | 2001 | 138 | 0.040 |
Why?
| | Anal Canal | 1 | 2021 | 102 | 0.040 |
Why?
| | Preoperative Period | 1 | 2020 | 142 | 0.040 |
Why?
| | Acidosis, Lactic | 1 | 2020 | 46 | 0.040 |
Why?
| | Decompression, Surgical | 1 | 2020 | 112 | 0.040 |
Why?
| | Oxidative Phosphorylation | 1 | 2020 | 194 | 0.040 |
Why?
| | Homozygote | 1 | 2020 | 201 | 0.040 |
Why?
| | Sacrococcygeal Region | 1 | 2019 | 6 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3307 | 0.040 |
Why?
| | Carotid Artery Diseases | 1 | 2019 | 61 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2020 | 309 | 0.040 |
Why?
| | Skull Fractures | 1 | 2019 | 38 | 0.040 |
Why?
| | Antibodies, Helminth | 1 | 2018 | 6 | 0.040 |
Why?
| | Radiation Exposure | 1 | 2019 | 53 | 0.040 |
Why?
| | Diaper Rash | 1 | 2018 | 5 | 0.040 |
Why?
| | Signal-To-Noise Ratio | 1 | 2019 | 64 | 0.040 |
Why?
| | Sheep | 1 | 2021 | 864 | 0.040 |
Why?
| | Kallmann Syndrome | 1 | 2018 | 7 | 0.040 |
Why?
| | Hemispherectomy | 1 | 2018 | 2 | 0.040 |
Why?
| | Nasopharyngeal Neoplasms | 1 | 2018 | 20 | 0.040 |
Why?
| | Urinary Bladder, Neurogenic | 1 | 2018 | 39 | 0.040 |
Why?
| | Mastectomy | 1 | 1999 | 148 | 0.040 |
Why?
| | Urinary Incontinence | 1 | 2018 | 65 | 0.040 |
Why?
| | Weight Gain | 1 | 2022 | 532 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 92 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2018 | 326 | 0.030 |
Why?
| | Cell Proliferation | 2 | 2017 | 2480 | 0.030 |
Why?
| | Cell Line, Tumor | 2 | 2017 | 3392 | 0.030 |
Why?
| | Informed Consent | 1 | 1999 | 188 | 0.030 |
Why?
| | Choice Behavior | 1 | 1999 | 172 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2020 | 1047 | 0.030 |
Why?
| | Meningitis | 1 | 2018 | 81 | 0.030 |
Why?
| | Constipation | 1 | 2018 | 98 | 0.030 |
Why?
| | Diagnostic Imaging | 1 | 2020 | 320 | 0.030 |
Why?
| | National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2017 | 6 | 0.030 |
Why?
| | Overweight | 1 | 2022 | 571 | 0.030 |
Why?
| | Models, Theoretical | 1 | 2020 | 578 | 0.030 |
Why?
| | Trauma Centers | 1 | 2019 | 428 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2020 | 540 | 0.030 |
Why?
| | Kinetics | 1 | 2020 | 1645 | 0.030 |
Why?
| | Age of Onset | 1 | 2018 | 514 | 0.030 |
Why?
| | Eosinophilia | 1 | 2018 | 218 | 0.030 |
Why?
| | Wounds, Nonpenetrating | 1 | 2019 | 304 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2020 | 1076 | 0.030 |
Why?
| | Rhinitis | 1 | 2018 | 171 | 0.030 |
Why?
| | Labor, Obstetric | 1 | 2016 | 66 | 0.030 |
Why?
| | Oximetry | 1 | 2016 | 118 | 0.030 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 95 | 0.030 |
Why?
| | Mucormycosis | 1 | 2015 | 22 | 0.030 |
Why?
| | Treatment Outcome | 2 | 2023 | 10923 | 0.030 |
Why?
| | Electroencephalography | 1 | 2018 | 444 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 980 | 0.030 |
Why?
| | Diet Therapy | 1 | 2015 | 37 | 0.030 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2015 | 82 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 1999 | 766 | 0.030 |
Why?
| | Metagenomics | 1 | 2015 | 177 | 0.030 |
Why?
| | Data Collection | 1 | 2017 | 657 | 0.030 |
Why?
| | Neurosurgical Procedures | 1 | 2016 | 204 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1742 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1123 | 0.030 |
Why?
| | Body Mass Index | 1 | 2022 | 2349 | 0.030 |
Why?
| | Streptococcal Infections | 1 | 2015 | 148 | 0.030 |
Why?
| | Venous Thrombosis | 1 | 2015 | 190 | 0.020 |
Why?
| | Mass Screening | 1 | 2001 | 1292 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2014 | 398 | 0.020 |
Why?
| | Visual Acuity | 1 | 2015 | 428 | 0.020 |
Why?
| | Acute Disease | 1 | 2015 | 994 | 0.020 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 236 | 0.020 |
Why?
| | Branchial Region | 1 | 2012 | 38 | 0.020 |
Why?
| | Infant, Premature | 1 | 2017 | 578 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1032 | 0.020 |
Why?
| | Animals | 3 | 2021 | 37217 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 2030 | 0.020 |
Why?
| | Time Factors | 2 | 2019 | 6851 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2023 | 5520 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1641 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 416 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2014 | 1229 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2015 | 553 | 0.020 |
Why?
| | Staphylococcal Infections | 1 | 2015 | 387 | 0.020 |
Why?
| | Quality of Life | 1 | 2023 | 2954 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2020 | 1729 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4555 | 0.020 |
Why?
| | Research Design | 1 | 2017 | 1118 | 0.020 |
Why?
| | Biomedical Research | 1 | 2017 | 694 | 0.020 |
Why?
| | Length of Stay | 1 | 2015 | 1238 | 0.020 |
Why?
| | Aged | 4 | 2019 | 24024 | 0.020 |
Why?
| | Anxiety | 1 | 2016 | 1072 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 2962 | 0.020 |
Why?
| | Polymethyl Methacrylate | 1 | 2005 | 22 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2018 | 5803 | 0.010 |
Why?
| | Catheterization | 1 | 2004 | 181 | 0.010 |
Why?
| | Middle Aged | 3 | 2019 | 33604 | 0.010 |
Why?
| | Aged, 80 and over | 2 | 2005 | 7677 | 0.010 |
Why?
| | Canada | 1 | 2001 | 407 | 0.010 |
Why?
| | Disease Management | 1 | 1999 | 622 | 0.010 |
Why?
| | Patient Acceptance of Health Care | 1 | 1999 | 858 | 0.010 |
Why?
|
|
Mirsky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|